By Shane Dilworth

The growing body of case law over insurers' duty to defend lawsuits brought by state and local governments over the opioid epidemic will lead to more strategic decisions about the most advantageous venue for filing coverage disputes, experts say.

By Bonnie Eslinger

Teva and Cephalon improperly peddled their painkiller Fentora even after Cephalon reached a 2008 plea agreement to resolve criminal claims it marketed a different opioid for unapproved uses, San Francisco's lawyer told the federal judge overseeing a bench trial on claims the companies and others illegally fueled the city's opioid epidemic.

By Jeff Overley

Arnold & Porter must face a multimillion-dollar sanctions bid for allegedly obstructing New York opioid litigation even though its former client Endo Pharmaceuticals exited the case with a $50 million settlement, an Empire State judge ruled Wednesday.

By Bonnie Eslinger

Allergan, Teva, Walgreens and Anda broke "defined rules of the road" in how they marketed opioids to boost sales, putting profits over patient safety, a pharmaceutical marketing expert testified Wednesday in a bellwether trial over claims that the four companies illegally fueled San Francisco's opioid epidemic.

By Cara Salvatore

West Virginia's attorney general has reached a settlement worth $161.5 million to resolve opioid-crisis claims against drugmakers Teva and Allergan, he announced Wednesday morning before closing arguments in a weekslong trial.